Why the study?
Does the Cordis Cypher Select drug-eluting stent reduce the long-term risk of stent thrombosis or restenosis compared to the Boston Scientific Liberte bare metal stent in patients with stable angina or acute coronary syndrome?
Does the Cordis Cypher Select drug-eluting stent reduce the long-term risk of stent thrombosis or restenosis compared to the Boston Scientific Liberte bare metal stent in patients with stable angina or acute coronary syndrome?
First-generation drug-eluting stents (Cordis Cypher Select) show an initial benefit over bare metal stents up to one year, but carry a substantially higher risk of late stent thrombosis and restenosis thereafter.
Answers are grounded in this paper and cite their sources.
Supports caution on late events after first-generation DES; leaves open randomized confirmation versus bare metal stents.
AIMS: Long-term comparisons between Drug-eluting stent and bare metal stent are not well-studied. The aim of this study was to compare two stents that were previously frequently used in regard to long-term risk of restenosis and stent thrombosis (ST). METHODS AND RESULTS: We used data from the SCAAR registry. Consecutive procedures performed between 2004 and 2014 for stable angina, UA/NSTEMI and STEMI were included. We compared two different stents: Cordis Cypher Select (C-CS), and Boston Scientific Liberte (BS-L), modeling data with multilevel Cox proportional-hazards regression. The primary endpoint was time to first occurrence of either ST or restenosis. During the study period 2210 C-CS and 6941 B-SL were implanted in 5,314 patients. Mean follow-up time was 2,288 days for C-CS and 2,297 days for BS-L. Treatment with C-CS was associated with lower risk for restenosis or ST up to one year from index procedure (HR 0.41; 95% CI 0.32-0.52; P < .001). However, after one year of follow-up, risk was substantially higher in C-CS (HR 2.81; 95% CI 2.25-3.50; P < .001). CONCLUSION: Treatment with C-CS was not associated with better outcome than BS-L. Continuation of restenosis and ST long after the index procedure with C-CS present a major concern for patient safety.
No takes yet. Share an insight, caveat, or question.
Völz et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: